Blinatumomab, which recently completed clinical trials and has won approval from the FDA, is a drug designed to treat acute ...

SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the bispecific T-cell engager ...